• A 83-01: Selective TGF-β Inhibition for EMT & Organoid Mo...

  2025-10-23

  A 83-01 redefines selective TGF-β type I receptor inhibition, powering advanced models of epithelial-mesenchymal transition (EMT), cellular growth suppression, and organoid fidelity. Its robust performance and versatile solubility profile enable reproducible workflows in cancer, fibrosis, and stem cell research.

• A 83-01: Precision TGF-β Pathway Inhibition for Dynamic O...

  2025-10-22

  Explore how A 83-01, a selective TGF-β type I receptor inhibitor, enables tunable control of human organoid self-renewal and differentiation. This in-depth analysis reveals advanced strategies and mechanistic insights for EMT, cancer, and fibrosis research.

• A 83-01: Precision Inhibition of TGF-β Signaling for Stem...

  2025-10-21

  Explore how A 83-01, an advanced ALK-5 inhibitor, uniquely enables targeted TGF-β signaling pathway inhibition for in-depth stemness, EMT, and liver regeneration studies. Discover novel mechanistic insights and translational potential beyond conventional applications.

78 records 6/6 page Previous First page 上5页 6